{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:03Z","timestamp":1786991283991,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jad.2022.12.042","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T02:06:29Z","timestamp":1672106789000},"page":"239-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms"],"prefix":"10.1016","volume":"324","author":[{"given":"Aki","family":"Nikolaidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaelle","family":"Lancelotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gukasyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jad.2022.12.042_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acsptsci.1c00018","article-title":"Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes","volume":"4","author":"Agin-Liebes","year":"2021","journal-title":"ACS Pharmacol.Transl.Sci."},{"issue":"9","key":"10.1016\/j.jad.2022.12.042_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016025","article-title":"Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting","volume":"7","author":"Argento","year":"2017","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.jad.2022.12.042_bb0015","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2022.12.042_bb0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881116678781","article-title":"The Challenging Experience Questionnaire: characterization of challenging experiences with psilocybin mushrooms","volume":"30","author":"Barrett","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.042_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jval.2014.10.007","article-title":"Measuring change in quality of life: bias in prospective and retrospective evaluation","volume":"18","author":"Blome","year":"2015","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jad.2022.12.042_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2022.12.042_bb0035","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jad.2022.12.042_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.jad.2022.12.042_bb0045","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jad.2022.12.042_bb0050","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.164.11.1197","article-title":"Response, partial response, and nonresponse in primary care treatment of depression","volume":"164","author":"Corey-Lisle","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.jad.2022.12.042_bb0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0269881118769063","article-title":"The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: benefits, consequences, patterns of use, subjective effects, and reasons for consumption","volume":"32","author":"Davis","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2022.12.042_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00952990.2018.1545024","article-title":"5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety","volume":"45","author":"Davis","year":"2019","journal-title":"Am.J.DrugAlcohol Abuse"},{"key":"10.1016\/j.jad.2022.12.042_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J. Contextual Behav. Sci."},{"key":"10.1016\/j.jad.2022.12.042_bb1000","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy for major depressive disorder: A randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiat."},{"issue":"3","key":"10.1016\/j.jad.2022.12.042_bb0075","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/acs.jmedchem.9b01404","article-title":"Identification of psychoplastogenic N, N-dimethylaminoisotryptamine (isoDMT) analogues through structure-activity relationship studies","volume":"63","author":"Dunlap","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jad.2022.12.042_bb0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/acps.12904","article-title":"Effects of psilocybin therapy on personality structure","volume":"138","author":"Erritzoe","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.jad.2022.12.042_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr.Drug Abuse Rev."},{"issue":"9","key":"10.1016\/j.jad.2022.12.042_bb0095","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.042_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00955","article-title":"Persisting reductions in cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: an online survey","volume":"10","author":"Garcia-Romeu","year":"2020","journal-title":"Front.Psychiatry"},{"key":"10.1016\/j.jad.2022.12.042_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jad.2022.12.042_bb0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.jad.2022.12.042_bb0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2022.12.042_bb0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.jad.2022.12.042_bb0125","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2022.12.042_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.042_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective twelve-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2022.12.042_bb0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.042_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.623985","article-title":"Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness","volume":"12","author":"Kettner","year":"2021","journal-title":"Front.Pharmacol."},{"issue":"7","key":"10.1016\/j.jad.2022.12.042_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041778","article-title":"A systematic review of comparative efficacy of treatments and controls for depression","volume":"7","author":"Khan","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jad.2022.12.042_bb0160","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1177\/0962280213502437","article-title":"A comparison of machine learning methods for classification using simulation with multiple real data examples from mental health studies","volume":"25","author":"Khondoker","year":"2016","journal-title":"Stat. Methods Med. Res."},{"issue":"3","key":"10.1016\/j.jad.2022.12.042_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2020.1737763","article-title":"Use of benefit enhancement strategies among 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) users: associations with mystical, challenging, and enduring effects","volume":"52","author":"Lancelotta","year":"2020","journal-title":"J. Psychoactive Drugs"},{"issue":"Suppl. 8","key":"10.1016\/j.jad.2022.12.042_bb0170","first-page":"4","article-title":"The burden of depression and anxiety in general medicine","volume":"62","author":"Lecrubier","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.042_bb0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jad.2022.12.042_bb0180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-5906.2012.01685.x","article-title":"Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin","volume":"51","author":"MacLean","year":"2012","journal-title":"J. Sci. Study Relig."},{"key":"10.1016\/j.jad.2022.12.042_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116678","article-title":"Bagging improves reproducibility of functional parcellation of the human brain","volume":"214","author":"Nikolaidis","year":"2020","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.jad.2022.12.042_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-87270-3","article-title":"The Coronavirus Health and Impact Survey (CRISIS) reveals reproducible correlates of pandemic-related mood states across the Atlantic","volume":"11","author":"Nikolaidis","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2022.12.042_bb0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpsychires.2021.12.058","article-title":"Heterogeneity in COVID-19 pandemic-induced lifestyle stressors and predicts future mental health in adults and children in the US and UK","volume":"147","author":"Nikolaidis","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.12.042_bb0210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11136-011-9952-1","article-title":"The inclusion of \u2018then-test\u2019 questions in post-test questionnaires alters post-test responses: a randomized study of bias in health program evaluation","volume":"21","author":"Nolte","year":"2012","journal-title":"Qual. Life Res."},{"issue":"2","key":"10.1016\/j.jad.2022.12.042_bb0215","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"7","key":"10.1016\/j.jad.2022.12.042_bb0220","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.10r06218blu","article-title":"The pharmacologic treatment of anxiety disorders: a review of progress","volume":"71","author":"Ravindran","year":"2010","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.jad.2022.12.042_bb0225","series-title":"Mental health","author":"Ritchie","year":"2018"},{"key":"10.1016\/j.jad.2022.12.042_bb0230","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2022.12.042_bb0235","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2022.12.042_bb0240","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.042_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"Silhouettes: a graphical aid to the interpretation and validation of cluster analysis","volume":"20","author":"Rousseeuw","year":"1987","journal-title":"J. Comput. Appl. Math."},{"issue":"12","key":"10.1016\/j.jad.2022.12.042_bb0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/bs9120122","article-title":"A machine learning approach for studying the comorbidities of complex diagnoses","volume":"9","author":"S\u00e1nchez-Rico","year":"2019","journal-title":"Behav.Sci."},{"issue":"2","key":"10.1016\/j.jad.2022.12.042_bb0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1556\/2054.2019.033","article-title":"Inhaled 5-methoxy-N, N-dimethyltryptamine: supportive context associated with positive acute and enduring effects","volume":"4","author":"Sepeda","year":"2019","journal-title":"J.Psychedelic Stud."},{"issue":"9","key":"10.1016\/j.jad.2022.12.042_bb0260","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1017\/S0033291719000151","article-title":"Machine learning in mental health: a scoping review of methods and applications","volume":"49","author":"Shatte","year":"2019","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jad.2022.12.042_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-0780-3","article-title":"Deep learning in mental health outcome research: a scoping review","volume":"10","author":"Su","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"2021","key":"10.1016\/j.jad.2022.12.042_bb0270","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1038\/s41598-021-84746-0","article-title":"Examining changes in personality following shamanic ceremonial use of ayahuasca","volume":"11","author":"Weiss","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2022.12.042_bb0275","first-page":"1","article-title":"People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences","author":"Williams","year":"2020","journal-title":"DrugsEduc.Prev.Policy"},{"issue":"2","key":"10.1016\/j.jad.2022.12.042_bb0285","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722013908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722013908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:45:14Z","timestamp":1759031114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722013908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":52,"alternative-id":["S0165032722013908"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.042","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}